NCT06578247: An ongoing trial by Daiichi Sankyo
This trial is ongoing. It must report results 5 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06578247 |
|---|---|
| Title | A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 19, 2024 |
| Completion date | June 26, 2030 |
| Required reporting date | June 26, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |